SCHEMBL5873807

SCHEMBL5873807

O=C1Cc2c(ccc3nn[nH]c23)N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.35
PDK2 Q15119 1/20 0.35
CMA1 P23946 2/20 0.35
PDE3B Q13370 1/20 0.35
PDE3A Q14432 1/20 0.35
DRD2 P14416 4/20 0.33
DRD4 P21917 3/20 0.33
DRD3 P35462 3/20 0.33
P2RX7 Q99572 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
CHRM2 P08172 1/20 0.33
CYP3A4 P08684 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
ADRA2B P18089 1/20 0.33
DRD1 P21728 1/20 0.33
DRD5 P21918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2070779 0.75 NEK2 (0.36) AHRPDK2CMA1PDE3BPDE3A
SCHEMBL18289479 0.74 AHR (0.50) AHRPDK2CMA1PDE3BPDE3A
SCHEMBL6807733 0.68 DYRK1A (0.41) GSK3BCDK5CDK2GSK3A
SCHEMBL5773101 0.67 GSK3B (0.51) KDM4ELMNAGSK3BCDK5CDK5R1
SCHEMBL5873762 0.67 MAP3K11 (0.40) AHRPDK2CMA1PDE3BPDE3A
SCHEMBL5893583 0.67 CES1 (0.44) PDE3BPDE3ABLM
SCHEMBL9833113 0.66 AHR (0.46) AHRPDK2CMA1PDE3BPDE3A
SCHEMBL5894170 0.65 ABL1 (0.36) AHRPDK2CMA1PDE3BPDE3A
SCHEMBL18962468 0.63 CCNB2 (0.44) AHRPDK2CMA1DRD2DRD4
SCHEMBL5366153 0.63 GRIA1 (0.42) AHRPDK2CMA1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129253-B2 Compounds SMITHKLINE BEECHAM CORPORATION (US) 2006-10-31 US disclosed
US-7105529-B2 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects SMITHKLINE BEECHAM CORPORATION (US) 2006-09-12 US disclosed
US-6818632-B2 3-(anilinomethylene)oxindoles SMITHKLINE BEECHAM CORPORATION 2004-11-16 US disclosed
US-6498176-B1 INHIBITING TUMOR GROWTH VIA INHIBITION OF TUMOR-RELATED ANGIOGENESIS SMITHKLINEBEECHAM CORPORATION 2002-12-24 US disclosed
US-6369086-B1 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors SMITHKLINE BEECHAM CORPORATION 2002-04-09 US disclosed
US-6350747-B1 PROTEIN SERINE/THREONINE KINASE AND PROTEIN TYROSINE KINASE ENZYME INHIBITORS; ANGIOGENESIS INHIBITORS; ANTITUMOR AND ANTIPROLIFERATIVE AGENTS GLAXO WELLCOME INC. 2002-02-26 US disclosed